Publication & Citation Trends
Most Cited Works
Publications
36 total
Causes of Cardiovascular Hospitalization and Death in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial [ATTR-ACT]) PDF
Cited by 41
OpenAlex
Efficacy and safety of tafamidis doses in the <scp>Tafamidis in Transthyretin Cardiomyopathy Clinical Trial</scp> ( <scp>ATTR‐ACT</scp> ) and long‐term extension study PDF
Cited by 205
OpenAlex
Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy PDF
Cited by 116
OpenAlex
The Bioequivalence of Tafamidis 61‐mg Free Acid Capsules and Tafamidis Meglumine 4 × 20‐mg Capsules in Healthy Volunteers PDF
Cited by 53
OpenAlex
Impact of Tafamidis on Health-Related Quality of Life in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial) PDF
Cited by 40
OpenAlex
Efficacy of Tafamidis in Transthyretin Amyloid Cardiomyopathy in the ATTR-ACT Trial
Cited by 2
Semantic Scholar
Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR‐ACT) and long‐term extension study OA
Cited by 184
Semantic Scholar
Tafamidis Reduced the Decline in Health-Related Quality of Life in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT)
Cited by 2
Semantic Scholar
Research Topics
Receptor Mechanisms and Signaling
(12)
Amyloidosis: Diagnosis, Treatment, Outcomes
(12)
Neurotransmitter Receptor Influence on Behavior
(8)
Peptidase Inhibition and Analysis
(8)
Neuroscience and Neuropharmacology Research
(7)
Frequent Co-Authors
Affiliations
Pfizer (United States)
University of Washington
Juravinski Cancer Centre
University of Florida Health
Hôpital Notre-Dame